Clifford Chance and DLA Piper lead $11.9bn sale of baby food business to Nestle
Clifford Chance and DLA Piper have taken leading roles on Pfizer's $11.9 billion cash sale of its baby food business to Nestle.
Nestle is advised by US law firm Mayer Brown, with the legal team being led by M&A partners David Carpenter and John Boelter in New York and Chicago. The team also includes intellectual property partner Richard Assmus and tax partners James Barry and Lee Morlock in Chicago, Hong Kong M&A partner Mark Uhrynuk and Washington DC antitrust partners John Roberti and Adrian Steel.
King & Wood Mallesons is handling the due diligence for Nestle, and providing regulatory and competition advice with a team led by M&A partner Mike Barker.
Pfizer is advised by three firms: Skadden Arps Slate Meagher & Flom, Clifford Chance and DLA Piper. Skadden fielded a team that includes M&A partners Paul Schnell and Kenneth Wolff, tax partner Sally Thurston and IP and technology partner Jose Estevez. The Clifford Chance team was led by antitrust partner and Brussels chief Tony Reeves and China corporate partner Emma Davies.